Nicorette Invisipatch (Nicotine)

• Nicorette Invisipatch is a nicotine replacement therapy used in the management of tobacco dependence.
• Smoking cessation: provides a steady nicotine supply to reduce cravings and withdrawal symptoms in adult smokers.
• Tobacco dependence: supports gradual reduction of nicotine intake as part of a quit‑plan.
• Relapse prevention: helps maintain abstinence by mitigating occasional urges after quitting.

• Nicotine in the patch is absorbed through the skin and enters the bloodstream, where it acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. Activation of these receptors reduces the intensity of withdrawal symptoms and diminishes the urge to smoke, while the controlled release maintains relatively stable plasma nicotine concentrations, avoiding the peaks associated with cigarette smoking.

Nicorette Invisipatch may cause a range of adverse reactions, most of which are mild and localized to the application site.

Common Side Effects

• Skin irritation at the patch site
• Itching or redness
• Sleep disturbance or vivid dreams
• Nausea
• Headache
• Dizziness

Serious or Rare Side Effects

• Allergic reaction with rash, swelling or hives
• Severe skin necrosis or ulceration
• Rapid heart rate or palpitations
• Low blood pressure (hypotension)
• Chest pain

• Before using Nicorette Invisipatch, consider the following precautions to ensure safe and effective therapy.
• Cardiovascular assessment: evaluate for recent heart attack, uncontrolled angina, or severe hypertension.
• Non‑smokers and occasional smokers: avoid use, as nicotine exposure is unnecessary.
• Comprehensive quit plan: use the patch together with behavioral support and counseling.
• Pregnancy and breastfeeding: consult a healthcare professional, as safety data are limited.
• Children and pets: keep patches out of reach to prevent accidental exposure.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine can interact with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may amplify nicotine’s cardiovascular effects.
• Certain antihypertensive drugs (beta‑blockers, clonidine): nicotine can counteract blood‑pressure‑lowering actions.
• Insulin or oral hypoglycemics: nicotine may affect glucose control, requiring dose adjustments.

Moderate Interactions (Monitor Closely)

• CYP2A6 inhibitors (e.g., methoxsalen): can increase nicotine plasma levels.
• Warfarin: nicotine may alter anticoagulant metabolism.
• Oral contraceptives: nicotine can reduce hormonal efficacy.
• Antidepressants (SSRIs, tricyclics): monitor for enhanced side effects.